Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Expo on Google News

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Top Links You Must Click On


X-Change Corp. Acquires Both the Cannabis Science "Phytiva" Brand and the Cannabis Science Joint Venture with Dupetit Natural Products, GmbH, Based in Germany

DALLAS, Dec. 13, 2012 /PRNewswire/ -- X-Change Corporation (NASDAQ OTC: XCHC), a U.S. publicly-traded company has acquired both the Cannabis Science, Inc. (NASDAQ OTC: CBIS) "Phytiva" Brand of products, including all associated rights and companies, and the CBIS European joint venture with Dupetit Natural Products, GmbH. Dupetit brings a successful 18-year history as a cutting-edge German hemp Cosmoceutical and Nutraceutical specialty enterprise.

The first products to be released under the Phytiva Brand will be unique lines of anti-aging skin care and rejuvenation products with innovative and proprietary hemp formulations. These initial products are expected to include lip balms, extracts, supplements and dermal creams, all targeting a wide range of cosmetic and ailment-related usages.

The company will maintain an aggressive posture to develop on-going and dynamic lines of retail, professional, physician-based, and private-label products for over-the-counter (OTC) sales under the Brand "Phytiva." The immediate aim is to distribute its Cosmoceutical (cosmetic) and Nutraceutical (nutrition) products for OTC markets throughout Europe and North & South America.

X-Change Corp. will target the global Cosmoceutical market, which is estimated to be over $55 billion dollars on an annual basis.  Further, the company plans to market its anti-aging, rejuvenating products in a global campaign which is currently estimated to be more than $274 billion in the coming year, with $119 billion in fitness, disease, and appearance.

To accommodate expected growth, some members of the CBIS management team will be joining X-Change Corp. The Company has appointed the following individuals to the Board of Directors:

  • Robert Kane – President & Chief Executive Officer
  • Alfredo Dupetit – Executive Vice President, European Operations & Director
  • R. Wayne Duke - Director

With the launch of this venture, a new website is expected to be online live for those wanting more information. The website is viewable at www.phytiva.com which outlines products, corporate information, and investor information in a clean, streamlined, and user-friendly fashion. Biographies for each member of the Board of Directors are also available on the website.

About X-Change Corp.

X-Change Corp. has acquired both the Phytiva Brand of products and all associated rights and Companies and the European JV with Dupetit from Cannabis Science, Inc. (NASD OTC: CBIS). The Phytiva products acquired by X-Change Corp. are unique hemp-inclusive products for skin care and rejuvenation.  These are the first products of the company to be released publicly.  These initial products include lip balms, extracts, supplements, and dermal creams, targeting a wide range of cosmetic and ailment-related usages.

Forward Looking Statements

This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. X-Change Corp. does not undertake any duty nor does it intend to update the results of these forward-looking statements.

X-Change Corp.
President & CEO
Robert Kane
info@phytiva.com
www.phytiva.com
1.866.326.5595

 

 

SOURCE X-Change Corporation

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Enterprise Open Source Magazine Latest Stories . . .
Silver shows that predictions in areas such as economics have been less successful, e.g. he examines why many economists missed the recession, and why supposedly expert forecasters get election predictions wrong so often. For example, before the recession of 2008, the assumption was ma...
The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long development cycles that produce software that is ob...
You can then easily piece together full transaction traces by ordering all method calls by sequence number. Further analysis can be applied to this information for a number of purposes. For example, by analysing the transactions, developers can easily construct design diagrams that can...
Every day and every second, the system administrator gets tones of information on the network operation, network devices’ operation, and messages from users; he sets dozens of challenges, which must help to avoid the existing and possible problems in the future. Often, it is rather dif...
With the increasing complexity of software, organizations are more cognizant than ever about the potential pitfalls of including open source code in their products. Below are some quick tips to continue leveraging open source code, while keeping your manager and legal department happy.
The industry is heated with debates on whether adopting private or public cloud is the smartest, best, cheapest, you name it choice. But this debate is missing the mark. Businesses shouldn’t be discussing public vs. private, but rather how can they make the two work together to their g...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE